How do you decide between HSCT and immunosuppressive therapy for treating hepatitis associated aplastic anemia?

For young people with a donor, the primary therapy is transplantation. It is curative in the vast majority of patients, hepatitis-associated AA is much less likely to respond to immunotherapy.